Avvisato, Roberta, Stanislovas S Jankauskas, Fahimeh Varzideh, Urna Kansakar, Pasquale Mone, and Gaetano Santulli. 2023. “Sortilin and hypertension”. Current Opinion in Nephrology and Hypertension 32 (2): 134.
Publications by Year: 2023
2023
Trimarco, Valentina, Raffaele Izzo, Angela Lombardi, Antonietta Coppola, Giuseppe Fiorentino, and Gaetano Santulli. 2023. “Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial”. Pharmacological Research 191: 106702.
Kao, Yu-Hsun, Yi-Jen Chen, Satoshi Higa, Nipon Chattipakorn, and Gaetano Santulli. 2023. “Transcription factors and arrhythmogenesis”. Frontiers in Physiology. Frontiers Media SA.
Avvisato, Roberta, Stanislovas S Jankauskas, and Gaetano Santulli. 2023. “Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure”. The Journal of Pharmacology and Experimental Therapeutics 384 (1): 227-30.
Sardu, Celestino, Gaetano Santulli, Gianluigi Savarese, Maria Consiglia Trotta, Cosimo Sacra, Matteo Santamaria, Mario Volpicelli, et al. 2023. “Endothelial Dysfunction Drives CRTd Outcome at 1-Year Follow-Up: A Novel Role as Biomarker for miR-130a-5p”. International Journal of Molecular Sciences 24 (2): 1510.
Paolisso, Pasquale, Luca Bergamaschi, Felice Gragnano, Emanuele Gallinoro, Arturo Cesaro, Celestino Sardu, Niya Mileva, et al. 2023. “Reply to SGLT-2 inhibitors: Post-infarction interventional effects”. Pharmacological Research 189: 106664.
Santulli, Gaetano. 2023. “Non-coding RNAs in clinical practice: From biomarkers to therapeutic tools”. Journal of Pharmacology and Experimental Therapeutics. ASPET.
Mone, Pasquale, Stefano De Gennaro, Salvatore Frullone, Anna Marro, and Gaetano Santulli. 2023. “Hyperglycemia drives the transition from pre-frailty to frailty: The Monteforte study”. European Journal of Internal Medicine 111: 135-37.
Tesorio, Tullio, Pasquale Mone, Antonio de Donato, Valentina Trimarco, and Gaetano Santulli. 2023. “Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 years”. Atherosclerosis 367: 37-39.
Gambardella, Jessica, Antonella Fiordelisi, Daniela Sorriento, Federica Cerasuolo, Antonietta Buonaiuto, Roberta Avvisato, Antonio Pisani, et al. 2023. “Mitochondrial microRNAs are dysregulated in patients with Fabry Disease”. Journal of Pharmacology and Experimental Therapeutics 384 (1): 72-78.